Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

Matthew Mutch

doi:10.1007/s10350-005-0239-x

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

Research output: Contribution to journal › Comment/debate

Original language	English
Number of pages	1
Journal	Diseases of the Colon and Rectum
Volume	49
Issue number	8
DOIs	https://doi.org/10.1007/s10350-005-0239-x
State	Published - Aug 1 2006

Access to Document

10.1007/s10350-005-0239-x

Cite this

@article{cbb5888023754cdca0c99409475a9442,

title = "Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer",

author = "Matthew Mutch",

year = "2006",

month = aug,

day = "1",

doi = "10.1007/s10350-005-0239-x",

language = "English",

volume = "49",

journal = "Diseases of the Colon and Rectum",

issn = "0012-3706",

number = "8",

}

TY - JOUR

T1 - Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

AU - Mutch, Matthew

PY - 2006/8/1

Y1 - 2006/8/1

UR - http://www.scopus.com/inward/record.url?scp=33747088543&partnerID=8YFLogxK

U2 - 10.1007/s10350-005-0239-x

DO - 10.1007/s10350-005-0239-x

M3 - Comment/debate

AN - SCOPUS:33747088543

SN - 0012-3706

VL - 49

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

IS - 8

ER -

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

Access to Document

Other files and links

Cite this